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Abstract
Background:  The aim of this study was to review evaluations and audits of primary care
complementary therapy services to determine the impact of these services on improving health
outcomes and reducing NHS costs. Our intention is to help service users, service providers,
clinicians and NHS commissioners make informed decisions about the potential of NHS based
complementary therapy services.
Methods:  We searched for published and unpublished studies of NHS based primary care
complementary therapy services located in England and Wales from November 2003 to April 2008.
We identified the type of information included in each document and extracted comparable data
on health outcomes and NHS costs (e.g. prescriptions and GP consultations).
Results: Twenty-one documents for 14 services met our inclusion criteria. Overall, the quality of
the studies was poor, so few conclusions can be made. One controlled and eleven uncontrolled
studies using SF36 or MYMOP indicated that primary care complementary therapy services had
moderate to strong impact on health status scores. Data on the impact of primary care
complementary therapy services on NHS costs were scarcer and inconclusive. One controlled
study of a medical osteopathy service found that service users did not decrease their use of NHS
resources.
Conclusion: To improve the quality of evaluations, we urge those evaluating complementary
therapy services to use standardised health outcome tools, calculate confidence intervals and
collect NHS cost data from GP medical records. Further discussion is needed on ways to
standardise the collection and reporting of NHS cost data in primary care complementary therapy
services evaluations.
Background
To make informed decisions about the usefulness of com-
plementary therapies, service users, clinicians and NHS
commissioners need good quality information on the
contribution complementary therapies can make to
improving health outcomes and reducing NHS costs.
Although there has been extensive debate on the best way
to assess the impact of complementary therapy treatments
on health outcomes [1-3], randomised controlled trials
tend to dominate. Randomised controlled trials are con-
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ducted in tightly controlled experimental environments
in which a particular intervention is targeted to a medi-
cally defined symptom (e.g. acupuncture for migraine
headaches). When treatments are removed from this
experimental context and integrated into the real world of
healthcare service delivery, these tight controls disappear
and local contextual factors may alter the impact of the
treatments. Hence, in investigating the potential useful-
ness of complementary therapies as part of mainstream
healthcare provision, research into the effectiveness of
treatments and the impact of services is necessary.
To date, however, the majority of research has been into
the therapeutic effectiveness of complementary therapy
treatments, with approximately 1500 trial based papers
published annually [4]. More recently, the cost effective-
ness of complementary therapy treatments has become a
focus. A review of 14 studies of complementary therapy
treatments meeting quality criteria found that seven treat-
ments were cost effective, including guided imagery, relax-
ation and potassium diets for cardiac patients and
osteopathy and chiropractic for neck pain [5]. Another
economic review of five complementary therapy treat-
ments concluded that four treatments resulted in addi-
tional costs to the NHS compared to usual care, largely to
cover the costs of the practitioner. They also found that
the estimates of cost of the complementary therapy treat-
ments compared favourably with other interventions
approved for use in the NHS [6]. Nonetheless, although
research evidence on the clinical and cost effectiveness of
complementary therapy treatments is growing, we have
less information on the impact of complementary therapy
services on health outcomes or NHS costs.
One attempt to address this was a report by Christopher
Smallwood and colleagues published in 2005 [7]. Draw-
ing on three case sites where complementary therapy serv-
ices were provided in NHS settings, the authors came to
the conclusion that [In the] majority of cases, specific condi-
tions have improved, as have patients' general health and sense
of well-being... [and] there seems to be good reason to believe
that a number of CAM (complementary and alternative) treat-
ments offer the possibility of significant savings in cost [7].
Perhaps unsurprisingly, given the controversy surround-
ing NHS provision of complementary therapies, the cred-
ibility of this report was challenged [8]. Notwithstanding,
these were possibly overly bold assertions, in light of the
limited quantity and questionable quality of some of the
case study data.
Aim of this study
In a previous exercise, we collected evaluations of 25 com-
plementary therapy services to identify the methodologies
used to assess services [9]. In addition, we explored the
relationship between evaluation content and methodol-
ogy and NHS funding and found that a favourable report
did not necessarily result in NHS funding. Subsequently,
we interviewed NHS funders and found that although
health outcome information was useful, information on
the impact of complementary therapy services on NHS
resource utilisation (e.g. GP consultations, prescription
and hospital services) was necessary to inform commis-
sioning decisions [10].
We have since continued to collect service evaluations and
the purpose of this paper is to report on the data con-
tained within this larger collection of documents. Specifi-
cally, our aim is to identify the potential impact of
primary care complementary therapy services on health
outcomes and NHS costs, as reported in complementary
therapy service evaluations. The target audiences for this
paper are NHS commissioners, who may be considering
provision of complementary therapy services, and current
and future providers of NHS based complementary ther-
apy services, who can build on the experiences of col-
leagues conducting earlier evaluations.
Methods
Search strategy
Because the majority of complementary therapy services
are located within primary care, we limited our review to
this sector. We collected published and unpublished eval-
uations from November 2003 to April 2008. A rigorous,
comprehensive searching strategy was devised including:
Contacting colleagues at the Foundation for Integrated
Health, mid-Devon Primary Care Research Group and the
Universities of Bristol, Sheffield, Thames Valley and West-
minster, who had conducted evaluations and/or were net-
worked to identify others who had.
Telephoning professional complementary therapy organ-
isations e.g. Society of Homeopaths, British Council of
Acupuncture, General Chiropractic Council, General
Osteopathic Council.
Identifying potential studies from bibliographies of
reports previously collected.
Searching the database of registered users for the SF36 and
MYMOP questionnaires.
Searching PubCAM, AMED (Allied and Complementary
Medicine) and Google Scholar.
Hand searching the archives of several journals including
Complementary Therapies in Medicine, Homeopathy and Acu-
puncture in Medicine.BMC Complementary and Alternative Medicine 2009, 9:5 http://www.biomedcentral.com/1472-6882/9/5
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Search terms were: audit, general practice, primary care,
complementary, alternative, homeopathy, acupuncture,
evaluation and service. A full list of all evaluations located
is available on request.
Inclusion and exclusion criteria
We included documents if the service was located within
England or Wales, was delivered by NHS clinicians or pro-
fessional therapists and was situated in a NHS primary
care setting. An exception was the inclusion of the Lewi-
sham service [11]. Although outpatient hospital based,
this evaluation was included because it was one of only
two which employed a randomised controlled trial meth-
odology and was similar to other primary care based serv-
ices. We excluded evaluations if:
they reported throughput alone (e.g. numbers of patient
seen)
they described solely the setting up of the service
the service setting was private, a charity or outside Eng-
land or Wales
the service was part of an acute hospital department e.g.
physiotherapists using acupuncture for pain
Because of the lack of high quality evaluations, no studies
were excluded on methodological grounds.
Data extraction and analysis
We devised a proforma to identify the type of information
contained in the reports including health outcome tools
(e.g. SF36, SF12, MYMOP, Glasgow Homeopathic Hospi-
tal Outcome Score, etc.) and NHS cost data (i.e. hospital,
GP consultation or prescription costs). We then selected
evaluations which collected health status data, using SF36
or MYMOP. These outcome tools were chosen because
they were the most commonly used standardised health
status questionnaires and so comparison across different
services was easier.
The SF36 is a questionnaire which asks the service user to
assess their health status in eight domains, including
physical functioning, role physical, social functioning,
pain, vitality, mental health, role emotional and general
health [12]. For example, for 'physical functioning'
respondents are asked to score a number of statements
about their specific abilities to climb stairs or walk a mile
while for 'role physical', respondents score statements
about the extent of their ability to perform physical tasks
generally. Although there is considerable debate about
interpretation of SF36 scores, it is generally held that an
improvement of 10 points or more indicates a strong
effect (see http://www.sf36.org 'norm based scoring and
interpretation').
MYMOP asks the service user to identify and then rate the
first and second priority symptoms that "bother" them the
most, an activity affected by those symptoms and overall
wellbeing on a scale of 0 to 6 [13]. In some cases, a profile
score, which amalgamates the scores from symptoms 1
and 2, wellbeing and activity, is calculated. An improve-
ment of 1 point or more is considered clinically signifi-
cant (see http://www.pms.ac.uk/mymop).
In addition to selecting evaluations with SF36 and
MYMOP health status data, we also selected evaluations
with extractable NHS cost data obtained from medical
records. Once all relevant documents were identified, we
then extracted details including:
number of service users
data collection time points
baseline and follow up health status scores
baseline and follow up rates and costs of prescriptions, GP
consultations and hospital consultations
confidence intervals
p values.
If confidence intervals were missing and it was possible,
we calculated the confidence intervals ourselves.
We gathered the results from individual service evalua-
tions into outcome specific tables (i.e. SF36, MYMOP,
prescriptions and GP consultations) and compared results
across the services. For costs relating to use of hospital
services, the data could not be combined into one table
and so the data from the two relevant complementary
therapy services are presented separately. We considered
synthesizing the data for each table, but decided against
this as the therapies offered, service models and ways of
collecting the data differed considerably between sites.
Results
In total, we collected 49 documents for 40 services. Fur-
ther details about the methodology and content of the
reports have been published previously [9]. Of the docu-
ments collected, we found 21 documents for 14 services
contained extractable data on NHS costs and/or health
status. Details of the services and evaluation documents
are summarised in Additional file 1.BMC Complementary and Alternative Medicine 2009, 9:5 http://www.biomedcentral.com/1472-6882/9/5
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Health status – SF36
Of the 14 services meeting our criteria, six administered
and reported SF36 data that could be extracted (Addi-
tional file 2) [11,14-17]. Confidence intervals were avail-
able for four of the six service evaluations. Across the
evaluations, four of the eight SF36 domains consistently
have confidence intervals which do not cross zero for the
average difference between baseline and follow up scores
(role physical, social functioning, pain and vitality). This
suggests that the complementary therapy services in this
review have had a positive effect on the scores for the
health status domains for these samples of service users.
The pain scores showed the largest change. The fewest
changes across these four services appear to have been
made in role emotional, mental health and general
health.
Of those using the SF36, only the Lewisham service also
administered this questionnaire to a waiting list control
group. The Lewisham service provided homeopathy, acu-
puncture and osteopathy delivered by professional thera-
pists for over 20 different conditions. The baseline SF36
was administered before the first treatment and follow up
occurred at the last session or three months after baseline
(whichever came first). One hundred and seventy nine
people in the treatment group and 151 in the control
group completed baseline and follow up SF36 question-
naires. Results suggest a moderate to strong improvement
for seven of the eight SF36 areas; only physical function-
ing showed no change [11].
Health status – MYMOP
Of the 14 services included in the review, nine reported
MYMOP data, but only seven provided extractable data
(Additional file 3). In comparing the scores for the five
services with confidence intervals, overall the first symp-
tom identified by service users showed the greatest change
followed by the second symptom. The average change in
score was consistently greater than one, and in some cases
it was closer to a two and half point difference. This sug-
gests that these complementary therapy services had a
substantial effect on health status scores, as measured by
MYMOP, for these service users. Only the confidence
intervals for the activity domain for the Sheffield service
crossed zero (average difference 1.9, 95% CI -0.4 to 4.2),
which suggests that the Sheffield complementary therapy
service did not have a positive impact on the activity
scores for this sample of service users. This may be under-
standable as service users were suffering from the meno-
pause and symptoms do not tend to impact on activity
levels.
NHS costs
The quality and quantity of data on NHS costs was less
robust or available than data for health status. Seven eval-
uations reported cost data extracted from GP medical
records, one of which used randomised controlled trial
methodology. Although all of the reports had methodo-
logical flaws, two were of especially poor quality (Newcas-
tle [18] and St. Margaret's [19]). In these evaluations, a
sub-sample of patients was identified (unclear as to how
selected), relevant medical records were extracted and
then the findings for the sub-samples were extrapolated
across the entire service populations, resulting in guessti-
mates of potential savings. Nonetheless, as both of these
evaluations justified further funding of these services by
the NHS, and in the absence of better cost data, they are
reported here.
A recurring methodological problem is that NHS cost data
are less easily standardised than health status data. We
found that the different evaluations used different ways to
calculate costs. For example, prescription data was col-
lected and analysed as average costs of prescriptions per
month per patient, average number of prescriptions per
month per patient, proportion of patients who reduced
their number of prescriptions overall, total number of pre-
scriptions and total cost savings of reduction in prescrip-
tions by the entire sample. GP consultation data were
more homogeneous in that all data were reported as con-
sultation rates, but the time period varied between average
consultation rates per patient per month, per six months
or per year.
In looking at prescription costs, three out of six uncon-
trolled evaluations reported that service users reduced
their prescriptions substantially by 57% (Coventry [20]),
45% (Glastonbury [21]) and 39% (Newcastle [18]). St.
Margaret's reported potential savings of £8944. Results
from the Impact evaluation suggested that there was no
change in the number of prescriptions (change of 0.04,
95% CI -0.99 to 0.87) [16]. The prescription costs for serv-
ice users of Get Well UK increased after using the service
(average baseline cost per patient per month £3.24, 95%
CI £1.80 to £4.80 and average follow up cost per patient
per month £3.75, 95% CI £1.74 to £6.49) [22]. (Addi-
tional file 4)
In looking at GP consultation rates, three of the six uncon-
trolled evaluations reported that their sample of service
users consulted their GPs about a third less often (Glas-
tonbury [21] Newcastle [18] and Coventry [20]), while
the St. Margaret's evaluation [19] found that service users
consulted their GPs over two thirds less often. The results
for the Impact service evaluation found that there was
almost no change (change of 0.14, 95% CI -0.97, 1.83)
[22]. Data from Get Well UK indicated that GP consulta-
tion rates amongst their sample of service users increased
from an average of 0.5 per patient per month (95% CI 0.4,
0.7) at baseline to an average of 0.8 (95% CI 0.6 to 1.1) atBMC Complementary and Alternative Medicine 2009, 9:5 http://www.biomedcentral.com/1472-6882/9/5
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follow up. Moreover, the Get Well UK evaluation sug-
gested an increase in GP consultation costs per patient per
month with an average baseline cost of £11.27 (95% CI
£8.60, £13.90) and an average follow up cost of £17.53
(95% CI £11.40, £24.00) [22]. To put consultation rate
data into context, the average practice consultation rate
per listed patient per month in England was 0.44 in 2006
[23]. (Additional file 5)
The Get Well UK and Glastonbury reports provided data
on secondary care consultations. The Get Well UK evalua-
tion found that the rates of secondary care referrals and
diagnostic tests combined per month were reduced (aver-
age combined of 1.38 at baseline to average combined of
0.70 at follow up), as were their corresponding costs
(mean £112.64 at baseline to mean £64.72 at follow up)
[22]. The Glastonbury evaluation found that usage of
physiotherapy, x-rays, blood and urine, tests and consult-
ant referrals were all reduced for a sub-sample of 41
patients with a total saving of over £2500 [21].
Only the Randomised Osteopathic Manipulation Study
(ROMANS) collected NHS cost data for a control group.
This was a pragmatic randomised controlled trial to eval-
uate a medical osteopathy service [24]. Two hundred and
one patients with neck and back pain were randomised
into two groups: usual GP care or medical osteopathy
from a single GP practitioner. Service users in the active
group received three to four medical osteopathy consulta-
tions. Medical record data on healthcare utilisation for
101 people in the usual care group and 86 in the medical
osteopathy group were collected. Data for over twenty dif-
ferent NHS healthcare activities were collected, including
rates for prescriptions, GP consultations and secondary
care activities such as consultant and physiotherapy con-
sultations. When calculating costs for all conditions suf-
fered by the osteopathy service users and non-users, there
was no difference between the medical osteopathy group
and the control group (average total costs £22, 95% CI -
£159, £142). Costs related to spinal pain were higher in
the group using medical osteopathy than those who did
not (average cost difference of £65, 95% CI £32, £155).
This might be partly explained by the inclusion of the
costs of the medical osteopathy consultations themselves
[25]. (Table 1)
Discussion
Summary of key points
Few services collected data on health status using stand-
ardised health outcome tools and even fewer collected
data on NHS costs. Of those that did, the quality of the
evaluations was variable.
Table 1: NHS healthcare utilisation rates for ROMANS medical osteopathy service users and non-users for six months (during and 
after)
Activity Non-service users (SD) Medical osteopathy service 
users (SD)
Difference 
(95% Confidence Intervals*)
All GP contacts 3.26 (2.69) 3.16 (2.81) -0.10
GP contacts for spinal pain 1.75 (2.22) 1.49 (2.0) -0.26
All prescriptions 5.11 (7.41) 5.28 (8.62) +0.17
Analgesic/non-steroidal anti-
inflammatory drug prescriptions
1.3 (2.17) 1.21 (1.9) -0.09
All consultant contacts 0.28 (0.62) 0.26 (0.49) -0.02
Consultant contacts for spinal pain 0.09 (0.38) 0.06 (0.24) -0.03
All physiotherapy 0.81 (1.96) 0.38 (1.76) -0.43
Physiotherapy for spinal pain 0.73 (1.96) 0.36 (1.73) -0.37
Average total healthcare costs £307 (£687) £328 (£564) +£21 (-£142, £159)
Average total spine related costs £64 (£90) £129 (£283) +£65 (£32, £155)
* 95% confidence intervals of the difference cannot be calculated as standard deviation not provided
Differences in bold = difference in favour of medical osteopathy group
SD = standard deviationBMC Complementary and Alternative Medicine 2009, 9:5 http://www.biomedcentral.com/1472-6882/9/5
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In comparing research into the effectiveness of comple-
mentary therapy treatments  and the impact of comple-
mentary therapy services on health outcomes, we found
that service evaluations were largely positive. All service
evaluations collecting data on health status (SF36 or
MYMOP) without a control group showed a substantial
improvement in scores. When data were also collected for
a control group (Lewisham), health status scores contin-
ued to demonstrate positive changes. With regard to the
SF36, across evaluations both with and without a control
group, the greatest changes were consistently found in
role physical, social functioning, pain and vitality.
Although more studies are needed, this suggests that NHS
complementary therapy services may have an impact on
health outcomes.
Data from complementary therapy service evaluations on
NHS costs were much scarcer and less robust. Uncon-
trolled service evaluations found increases, decreases and
no change in prescriptions and GP consultations. Both
uncontrolled evaluations found decreases in secondary
care usage. The only controlled study investigating the
impact of a complementary therapy service on NHS costs
(ROMANS) found that the medical osteopathy service
made no impact on healthcare utilisation costs for all con-
ditions. Costs associated only with spinal pain, which
included the costs of the medical osteopathy consulta-
tions, were increased.
Strengths and limitations
A strength of this study is that this is the first comprehen-
sive attempt to collect and review the growing number of
evaluations of NHS complementary therapy services in
primary care. However, because of the scarcity of good
quality data, we can draw few conclusions about the
impact of these services on health status and NHS costs.
One limitation of this study is that very few evaluations
met our selection criteria of reporting standardised health
status or NHS cost data. A second limitation is that
amongst those who did, there were gaps in the reporting
of the data collection processes and inconsistencies across
the evaluations that made comparison difficult e.g. vary-
ing data collection time points, different health outcome
tools, prescriptions calculated as rates, costs and total sav-
ings etc. A third limitation is that only two service evalua-
tions collected data for control groups. Control groups are
used to demonstrate that any changes that have occurred
can be attributed to the intervention (in this case a com-
plementary therapy service) and would not have occurred
anyway. This is necessary to assure some (scientifically
minded) clinicians and Primary Care Trust managers of
the potential impact of complementary therapies on
health outcomes and NHS costs [26].
Implications
Because NHS based complementary therapy services are
often marginalised, face constant battles to secure funding
[27] and have limited access to research expertise, those
services that do carry out service evaluations deserve con-
gratulations. Nonetheless, evaluations of NHS primary
care complementary therapy services need greater rigour
to provide better understanding of the impact these serv-
ices can make on health outcomes and NHS costs. An ear-
lier attempt to address this was the BESTCAM Delphi
exercise which aimed to improve the content of comple-
mentary therapy service evaluations by identifying useful
data collection items [28]. Our intention is to focus on
improvements in the process of data collection and report-
ing.
The following figure illustrates a suggested scale of quality
markers for evaluations of complementary therapy serv-
ices. (Figure 1) At a basic level, those evaluating comple-
mentary therapy services could collect data on health
outcomes with standardised outcome tools such as
MYMOP and SF36, rather than designing their own ques-
tionnaires. Although there are many such tools available,
we found that MYMOP and SF36 were most commonly
used in complementary therapy service evaluations. In
comparing SF36 to MYMOP, the SF36 allows for better
identification of the domains where complementary ther-
apy services may score the largest improvement, but
MYMOP is more patient oriented. Both of these are avail-
able without charge on the Internet (see http://www.sf-
36.org and http://www.pms.ac.uk/mymop).
A further step in improving the quality of evaluations of
NHS complementary therapy services would be the inclu-
sion of confidence intervals around estimates. Confidence
intervals provide valuable information on the range of
values that might occur and give an indication of the
strength of the impact of an intervention (in this case, a
complementary therapy service). So, for example, for the
first symptom for the CHIPs service [29] there was an
average improvement of 1.9 for service users between
baseline and follow up MYMOP scores on a six point
scale. Using confidence intervals, we can say that we are
95% confident that the value of that difference within this
population will fall somewhere between 1.5 and 2.3,
which suggests a moderately strong impact. If a confi-
dence interval crosses zero, this suggests that the service
does not have an impact on improving the score for that
domain. Although potentially daunting, confidence inter-
vals are not difficult to calculate and instructions can be
found in Additional file 6.
A further improvement in the quality of evaluations
would be the collection of NHS cost data from GP medi-
cal records. This is a significant undertaking, as it requiresBMC Complementary and Alternative Medicine 2009, 9:5 http://www.biomedcentral.com/1472-6882/9/5
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obtaining permission to access medical records from GP
surgeries (and possibly ethics approval see http://
www.nres.npsa.nhs.uk), an understanding of medical ter-
minology and extensive time. Furthermore, there is great
variety in the way NHS cost data are collected as, unlike
health status data, there are not standardised tools. How-
ever, the evaluations in this review showed a trend
towards the calculation of GP consultation rates as aver-
age rates per patient over six or twelve months. Further
research is needed into the optimum way of collecting and
calculating prescription and secondary care data.
Once NHS cost data are collected, a further rung on the
quality marker scale would be to calculate confidence
intervals for cost data in addition to health status data.
Each of the first four stages on the quality marker triangle
would require increasing confidence with research lan-
guage and skills, although all of them could conceivably
be undertaken with little or no academic involvement.
However, the final step on the quality marker scale, to col-
lect standardised health status and NHS cost data with
confidence intervals for treatment and control groups, i.e.
complementary therapy service users and non-users,
would require significant engagement with academic
researchers, possibly from a registered clinical trial unit
(see http://www.ukcrn.org.uk). But such an endeavour
would also necessitate substantial outside funding. This
could help explain why so few randomised controlled tri-
als of complementary therapy services have taken place.
Moreover, even if conducting randomised controlled tri-
als were less challenging, we do not know the extent to
which randomised controlled trials actually influence cli-
nicians and NHS commissioners' decisions around com-
plementary therapy service provision [10].
Conclusion
In reviewing complementary therapy service evaluations,
we found that uncontrolled health status data suggest that
such services improve health outcome scores, but the data
on the impact of these services on NHS costs are scarcer
and inconclusive. Moreover, the overall quality of these
evaluations was poor. To improve the quality of evalua-
tions and increase understanding of the impact these serv-
ices may have, we urge those evaluating complementary
therapy services to use standardised health outcome tools,
calculate confidence intervals and consider the collection
of NHS cost data from GP medical records. Furthermore,
discussion with the wider NHS healthcare community is
needed on the optimum ways to standardise the collec-
tion and reporting of NHS cost data in evaluations of
complementary therapy services.
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